Lie of the Year: The Downplay and Denial of the Coronavirus
It's no worse than the flu, and other deadly disinformation about the coronavirus
Trump Administration
701-720 of 1,297 results
-
-
Trump’s Wrong. 15% ‘Herd Immunity’ Is Not on Par With Strength of a Vaccine
Experts agree that more than 70% of a population needs to be inoculated to reach “herd immunity.”
-
Trump Plan May Set Clock Ticking on Many Health Rules — Setting Off Alarms
The Department of Health and Human Services has proposed that the new administration review about 2,400 regulations that affect tens of millions of Americans, on everything from Medicare benefits to prescription drug approvals. Those not analyzed within two years would become void.
-
Trump Rule Gives Small Companies a New Tool to Help Workers Buy Health Coverage
Instead of taking on the expense of traditional health plans, some small businesses are setting up an “individual coverage health reimbursement arrangement” that allows them to give workers money to put toward comprehensive coverage on the individual insurance market. But consumer advocates are concerned they may shortchange some workers.
-
How Pharma Money Colors Operation Warp Speed’s Quest to Defeat COVID
A Trump administration maneuver allows executives who are leading the federal effort to keep investments in drug companies that would benefit from the pandemic response.
-
KHN’s ‘What the Health?’: Transition Troubles Mount as COVID Spreads
COVID-19 is spreading rapidly around the U.S. even before Thanksgiving promises to accelerate the trend. There are two promising vaccine candidates, but because President Donald Trump still refuses to concede the election and is holding up the official transition, President-Elect Joe Biden and his team cannot access plans for distributing those vaccines. Margot Sanger-Katz of The New York Times, Alice Miranda Ollstein of Politico and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
-
Trump’s Lame-Duck Status Leaves Governors to Wing It on COVID
As coronavirus cases surge, state officials can’t afford to wait for a new president to take office before taking action. But some governors’ initiatives seem to be little more than policy tweaks or symbolic gestures.
By Matt Volz -
Surprise Federal Drug Rule Directs Insurers to Reveal What They Pay for Prescription Drugs
A provision the Trump administration tucked into its final rule on health plan price transparency requires telling consumers what they will pay out-of-pocket for drugs and showing them what the plan paid.
By Harris Meyer -
KHN’s ‘What the Health?’: Transition Interrupted
Former Vice President Joe Biden is now the president-elect nearly everywhere but inside the Trump administration, where the president refuses to concede and has ordered officials not to begin a formal transition. That is a particular problem for health care as the COVID-19 pandemic surges. Meanwhile, there’s good news on the vaccine front, but it’s unlikely one will arrive by winter. And the ACA was back before the Supreme Court — again. Joanne Kenen of Politico, Stephanie Armour of The Wall Street Journal and Shefali Luthra of the 19th News join KHN’s Julie Rovner to discuss these issues and more. Plus, for extra credit, the panelists recommend their favorite health stories of the week they think you should read, too.
-
Trump’s Anti-Abortion Zeal Shook Fragile Health Systems Around the World
President-elect Joe Biden inherits a global health landscape changed by the Trump administration more than under any Republican president since Ronald Reagan.
By Sarah Varney -
Justices Bound to See ACA as ‘Indispensable,’ Says Californian Leading Defense
The U.S. Supreme Court will hear arguments Tuesday in a case that could overturn the Affordable Care Act. California Attorney General Xavier Becerra, who is defending the law with the backing of more than 20 other states, told California Healthline that he predicts the justices will uphold it.
-
A Biden Win and Republican Senate Might Lead to Gridlock on Health Issues
If Democrat Joe Biden is successful in his bid for the presidency but the Senate remains in GOP control, Democrats’ plans for major changes in health care may be curbed.
By Julie Rovner -
California’s Progressive — and Expensive — Health Care Ambitions Rely on Biden Win
There couldn’t be more at stake for California’s Democratic health care agenda in the presidential race. State lawmakers are already penning big-ticket legislation they hope to pursue should Democrat Joe Biden win, from single-payer to a new wealth tax.
By Angela Hart -
‘It’s Science, Stupid’: A School Subject Emerges as a Hot-Button Political Issue
Science is becoming increasingly politicized, so how will it fare on the campaign trail — in 2020 and beyond?
-
A $200 Debit Card Won’t Do Much for Seniors’ Drug Costs
President Donald Trump wants to send seniors $200 apiece. Beyond the legal and logistical problems, health care experts point out it does little to help someone with even typical prescription costs.
By Harris Meyer -
KHN’s ‘What the Health?’: As Cases Spike, White House Declares Pandemic Over
Former President Barack Obama says President Donald Trump is “jealous of COVID’s media coverage.” Indeed, Trump has complained at his rallies, attended by mostly maskless supporters, about how the media covers the pandemic — at a time when cases are rising rapidly across the nation. Meanwhile, open enrollment is about to begin for the Affordable Care Act in a year when many people need coverage, but the law’s future is not secure. Joanne Kenen of Politico, Tami Luhby of CNN and Anna Edney of Bloomberg News join KHN’s Julie Rovner to discuss these issues and more. Plus, Rovner interviews KHN’s Anna Almendrala about the latest KHN-NPR “Bill of the Month” installment.
-
A $10,000 Obamacare Penalty? Doubtful.
Experts said a penalty of $10,000 in one year would have been extremely unlikely.
-
The Trump Medicaid Record: Big Goals, Yet Few Successes
The Trump administration sought to shrink the federal-state health program for low-income Americans and give states more flexibility. But Democrats and the courts thwarted most of those efforts.
-
If Trump Wins, Don’t Hold Your Breath Waiting for That ACA Replacement Plan
The administration seeks to have the Supreme Court overturn the federal health law but has not explained how it would ensure Americans’ health care coverage.
By Julie Rovner -
Florida Fails to Attract Bidders for Canada Drug Importation Program
No private firms bid on the $30 million contract to set up and operate the state’s plan to bring in cheaper drugs. The setback is likely to delay by at least several months Florida’s effort to become the first state to import drugs under new federal regulations.